Proteon

PRTO NASDAQ
0.3297
+0.0136
+4.30%
Closed 16:00 08/21 EDT
Open
0.3202
Prev Close
0.3161
High
0.3400
Low
0.3111
Volume
180.67K
Avg Vol (3M)
1.03M
52 Week High
3.940
52 Week Low
0.2700
% Turnover
0.92%
Market Cap
6.46M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Proteon PRTO stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Proteon Therapeutics, Inc. is a late-stage biopharmaceutical company. The Company is focused on the development of pharmaceuticals to address patients with renal and vascular disease. The Company’s product candidate, vonapanitase, is a recombinant human elastase. The Company is developing vonapanitase to improve vascular access outcomes in patients with chronic kidney disease (CKD), undergoing or planning for hemodialysis.
MORE >

Recently

Name
Price
%Change